Why the study?
Subjects with metabolic syndrome commonly have atrial remodeling indicating risk for atrial fibrillation, but the specific VLDL lipid composition changes, statin effects, and correlations with atrial remodeling were undetermined.
Does statin therapy alter VLDL lipid composition, and is VLDL lipid composition associated with atrial remodeling in patients with metabolic syndrome?
Does statin therapy alter VLDL lipid composition, and is VLDL lipid composition associated with atrial remodeling in patients with metabolic syndrome?
The pathological lipid payload of VLDL in metabolic syndrome correlates with atrial remodeling, and statin therapy may attenuate some of these pro-remodeling lipid abnormalities.
VLDL lipid alterations in MetS were associated with atrial remodeling; hypothesis-generating for targeted interventions before practice change.
Subjects with metabolic syndrome (MetS) commonly have atrial remodeling, which indicates a risk for atrial fibrillation. This study determined MetS-related changes in lipid components in very-low-density lipoprotein (VLDL), which has been shown to cause atrial remodeling, the effect of statins on these changes, and the correlation between atrial remodeling and VLDL lipid compositions. Blood samples were collected from 12 non-MetS and 27 sex- and age-matched MetS subjects. Fourteen patients with MetS (MetS-off statin) discontinued statin therapy 14 days before the study, while the remaining 13 remained on it (MetS-on statin). The VLDLs were isolated and processed for mass-based lipid profiling. Lipidomic analyses were performed and associated with atrial remodeling markers measured using standard echocardiography and electrocardiography. Compared with the VLDL components of the non-MetS group, glucosyl/galactosyl ceramide, lyso-phosphatidylcholine, lyso-phosphatidylethanolamine, and triglycerides were enriched in the MetS-off statin group. Statin therapy attenuated all abnormally abundant lipid classes in MetS, except for triglycerides. In addition, lyso-phosphatidylcholine, lyso-phosphatidylethanolamine, and triglycerides were significantly correlated with atrial dilatation, and the latter two were also correlated with the PR interval. Enrichment of double bonds, which indicate unsaturated fatty acids, was also significantly correlated with atrial remodeling and P-wave duration. This study suggests that the pathological lipid payload of MetS-VLDL may contribute to atrial remodeling in patients.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: